Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
HEALTHEQUITY, INC. reported fiscal year ending January 31, 2024 results: revenue $975 million to $985 million, net income $9 million and $14 million, EPS $0.10 to $0.16 per diluted share. Guidance raised.
- Period
- fiscal year ending January 31, 2024
- Revenue
- $975 million to $985 million
- Net income
- $9 million and $14 million
- EPS
- $0.10 to $0.16 per diluted share
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
For the fiscal year ending January 31, 2024, management expects revenue of $975 million to $985 million. Its outlook for net income is between $9 million and $14 million, resulting in net income of $0.10 to $0.16 per diluted share.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
HEALTHEQUITY, INC. reported results: revenue $244.4 million, net income $4.1 million, EPS $0.05 per diluted share. Guidance raised.
- Revenue
- $244.4 million
- Net income
- $4.1 million
- EPS
- $0.05 per diluted share
- Guidance
- raised
- Result
- reported results
Exact text from the filing
in such a filing. --- EX-99.1 (EX-99.1) --- HealthEquity Reports First Quarter Ended April 30, 2023 Financial Results Highlights of the first quarter include: • Revenue of $244.4 million, an increase of 19% compared to $205.7 million in Q1 FY23. • Net income of $4.1 million, compared to net loss of $13.6 million in Q1 FY23, with non-GAAP net income of $42.8
View on SEC.gov